Cargando…
Increasing CD44(+)/CD24(- )tumor stem cells, and upregulation of COX-2 and HDAC6, as major functions of HER2 in breast tumorigenesis
BACKGROUND: Cancer cells are believed to arise primarily from stem cells. CD44(+)/CD24(- )have been identified as markers for human breast cancer stem cells. Although, HER2 is a well known breast cancer oncogene, the mechanisms of action of this gene are not completely understood. Previously, we hav...
Autores principales: | Wang, Kai-Hung, Kao, An-Pei, Chang, Chia-Cheng, Lee, Jau-Nan, Hou, Ming-Feng, Long, Cheng-Yu, Chen, Hung-Sheng, Tsai, Eing-Mei |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989327/ https://www.ncbi.nlm.nih.gov/pubmed/21044318 http://dx.doi.org/10.1186/1476-4598-9-288 |
Ejemplares similares
-
Tumorigenic and Metastatic Role of CD44(−/low)/CD24(−/low) Cells in Luminal Breast Cancer
por: Vikram, Rajeev, et al.
Publicado: (2020) -
miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis
por: Hsieh, Tsung-Hua, et al.
Publicado: (2014) -
Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017) -
Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011) -
Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2018)